Sustained virological response after prolonged treatment with peginterferon alfa-2a (40kd) (PEGASYS®) and ribavirin (COPEGUS®) in treatment-naive patients with chronic hepatitis C and detectable HCV RNA after week 4 of therapy:: Teravic-4 study

被引：4

作者：

Sanchez-Tapias, JM

Diago, M

Escartin, P

Enriquez, J

Moreno, R

Romero-Gomez, M

Barcena, R

Crespo, J

Andrade, R

机构：

[1] Roche, TeraViC4 Study Grp, Madrid, Spain

[2] H Clin Prov I, Barcelona, Spain

[3] H Gen, Valencia, Spain

[4] H Puerta Hierro, Madrid, Spain

[5] H Sant Pau, Barcelona, Spain

[6] H La Princesa, Madrid, Spain

[7] HU Valme, Seville, Spain

[8] H Ramon & Cajal, Madrid, Spain

[9] H Marques Valdecilla, Santander, Spain

[10] H Virgen Victoria, Malaga, Spain

来源：

关键词：

D O I：

10.1016/S0168-8278(04)90509-0

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

509

引用

页码：150 / 150

页数：1